Assesses primary immunodeficiency severity across B-cell (agammaglobulinemia, CVID), T-cell (SCID, DiGeorge), combined, and phagocyte defects to guide IVIG dosing, HSCT timing, and prophylactic antimicrobial regimens.
Assesses primary immunodeficiency severity across B-cell (agammaglobulinemia, CVID), T-cell (SCID, DiGeorge), combined, and phagocyte defects to guide IVIG dosing, HSCT timing, and prophylactic antimicrobial regimens
Each component has a specific meaning:
Note: Interpret the pid severity result against the thresholds and context described above.
Enter the B-cell (agammaglobulinemia, CVID), T-cell (SCID, DiGeorge), combined, phagocyte defects for the scenario you are assessing. Assesses primary immunodeficiency severity across B-cell (agammaglobulinemia, CVID), T-cell (SCID, DiGeorge), combined, and phagocyte defects to guide IVIG dosing, HSCT timing, and prophylactic antimicrobial regimens. Use the pid severity result to inform your calculation.